ATE157546T1 - Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit - Google Patents

Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit

Info

Publication number
ATE157546T1
ATE157546T1 AT88100233T AT88100233T ATE157546T1 AT E157546 T1 ATE157546 T1 AT E157546T1 AT 88100233 T AT88100233 T AT 88100233T AT 88100233 T AT88100233 T AT 88100233T AT E157546 T1 ATE157546 T1 AT E157546T1
Authority
AT
Austria
Prior art keywords
disease
levels
hormones
alzheimer
senile dementia
Prior art date
Application number
AT88100233T
Other languages
English (en)
Inventor
Chaovanee Aroonsakul
Original Assignee
Chaovanee Aroonsakul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chaovanee Aroonsakul filed Critical Chaovanee Aroonsakul
Application granted granted Critical
Publication of ATE157546T1 publication Critical patent/ATE157546T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT88100233T 1988-01-11 1988-01-11 Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit ATE157546T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88100233A EP0324037B1 (de) 1988-01-11 1988-01-11 Verwendung von Anabolika zur Herstellung eines Arzneimittels zur Behandlung von seniler Dementia und der Alzheimerschen Krankheit

Publications (1)

Publication Number Publication Date
ATE157546T1 true ATE157546T1 (de) 1997-09-15

Family

ID=8198634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88100233T ATE157546T1 (de) 1988-01-11 1988-01-11 Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit

Country Status (5)

Country Link
EP (1) EP0324037B1 (de)
AT (1) ATE157546T1 (de)
DE (1) DE3856017T2 (de)
ES (1) ES2109914T3 (de)
GR (1) GR3025576T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149786A (en) * 1989-10-12 1992-09-22 Chiron Corporation Dopamine releasing protein and antibody
IT9041720A1 (it) * 1990-10-26 1992-04-27 Fidia Spa Metodo per la diagnosi del parkinson idiopatico
AU6449594A (en) * 1993-04-02 1994-10-24 Ohio University Enhancement of learning and/or memory by a human somatotropin
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
ATE353653T1 (de) * 2003-07-29 2007-03-15 Acme Srl Verwendung von stanozolol zur herstellung von entzündungshemmenden und antidegenerativen arzneimitteln

Also Published As

Publication number Publication date
DE3856017D1 (de) 1997-10-09
GR3025576T3 (en) 1998-03-31
EP0324037B1 (de) 1997-09-03
DE3856017T2 (de) 1998-04-23
EP0324037A1 (de) 1989-07-19
ES2109914T3 (es) 1998-02-01

Similar Documents

Publication Publication Date Title
Tuite et al. Dopa‐responsive parkinsonism phenotype of Machado‐Joseph disease: confirmation of 14q CAG expansion
Hunter et al. Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication
De Volder et al. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration
EP0276723B1 (de) Vorläuferprotein des APC-Polypeptids, dafür codierende DNA und diagnostische Verwendung der DNA und des Proteins
Gruen et al. Growth hormone responses to hypoglycemia in postmenopausal depressed women
Weiskrantz et al. A study of forgetting in amnesic patients
EP0293974B1 (de) Verwendung von Sulfomucopolysacchariden zur therapeutischen Behandlung von Krankheiten des Alzheimertyps
Gibb et al. Pathological report of four patients presenting with cranial dystonias
Sachar et al. Human growth hormone response to levodopa: Relation to menopause, depression, and plasma dopa concentration
Inelmen et al. An open-ended question: Alzheimer’s disease and involuntary weight loss: which comes first?
Linkowski et al. The 24-hour profile of plasma prolactin in men with major endogenous depressive illness
Korenke et al. Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters
De Reuck et al. A double‐blind study of neurotropin in patients with acute ischemic stroke
ATE157546T1 (de) Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit
Bierich et al. New observations on midline defects: coincidence of anophthalmos, microphthalmos and cryptophthalmos with hypothalamic disorders
Jennekens-Schinkel et al. A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man
JP2850128B2 (ja) 老化度測定方法
Tattersall A history of growth hormone
Longatti et al. The CSF myelin basic protein in pediatric hydrocephalus
Bezard et al. Glutamatergic compensatory mechanisms in experimental parkinsonism
Paine et al. Atypical Variants of the ‘Ataxia Telangiectasia’Syndrome: Report of Two Cases, Including One with Apparent Dominant Inheritance
Wang et al. Thermoneutral Temperature Exposure Enhances Slow Wave Sleep with a Correlated Improvement in Amyloid Pathology in a Triple-Transgenic Mouse Model of Alzheimer’s Disease
Christensen et al. Plasma growth hormone in acromegalic patients
US5065748A (en) Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone
Hare et al. Acute porphyria: Two cases with autopsy reports

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee